PNA5
/ ProNeurogen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 03, 2026
Phase 1 Clinical Development Strategy for PNA5 in VCID: Translational Biomarkers, Neurovascular Mechanisms, and SAD/MAD Design
(CTAD 2026)
- No abstract available
Biomarker • Clinical • P1 data
1 to 1
Of
1
Go to page
1